Skip to content

MI-based PrEP Intervention

A Brief Motivational Interviewing-based Intervention to Improve HIV Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03313765
Enrollment
86
Registered
2017-10-18
Start date
2019-01-10
Completion date
2020-04-30
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PrEP Uptake

Brief summary

Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States. Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventing HIV infection among MSM. However, uptake in clinical settings has been slow for several reasons, including low awareness and education, low perceived HIV risk, concern for side-effects, and stigma associated with taking the medication. The purpose of the proposed study is to develop and evaluate a brief motivational interviewing (MI) intervention to promote PrEP uptake among MSM during the course of routine HIV screening at a public sexually transmitted disease (STD) clinic.

Interventions

BEHAVIORALMotivational interviewing (MI)

Brief MI intervention

OTHERStandard-of-care

Standard-of-care education and counseling

Sponsors

The Miriam Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. 18 years of age or older 2. Assigned male at birth and currently identify as male 3. Score at least 10 on the HIV Incident Risk Index for MSM 4. HIV-negative based on results of antibody test 5. English- or Spanish-speaking 6. Have access to a working phone 7. Have not taken PrEP

Exclusion criteria

1. Have previously taken PrEP 2. Symptoms of acute HIV infection at baseline 3. HIV positive 4. A clinical contraindication to PrEP (e.g., renal dysfunction) 5. Non-English or non-Spanish speaking

Design outcomes

Primary

MeasureTime frame
PrEP uptakeThree months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026